Agilent pd-l1 assay receives fda approval for use as companion diagnostic

Agilent pd-l1 assay receives fda approval for use as a companion diagnostic.agilent pd-l1 assay receives fda approval for use as a companion diagnostic.agilent technologies inc - assay will help guide treatment decisions in cases of non-small cell lung cancer.
A Ratings Summary
A Quant Ranking